One-and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancya randomized trial

Human Reproduction

Volumn 26, Issue 10, 2011, Pages 2690-2697

  Mentula, Maarit ^a   Suhonen, Satu ^b   Heikinheimo, Oskari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b City of Helsinki   (Finland)

Author keywords

Dosing interval; mifepristone; misoprostol; second trimester; termination of pregnancy

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; BLEEDING; CHILL; CONTROLLED STUDY; DILATION AND EVACUATION; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; IMMINENT ABORTION; INDUCED ABORTION; INFECTION; INTENTION TO TREAT ANALYSIS; LAPAROSCOPY; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PLACENTA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; SHIVERING; SIDE EFFECT; TEMPERATURE; TIME; TRANSVAGINAL ECHOGRAPHY; UTERUS PERFORATION; VAGINA DISCHARGE; VAGINAL DELIVERY; VISUAL ANALOG SCALE;

EID: 80052882293     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der218     Document Type: Article

References (25)

1. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004;69:51-58. (Pubitemid 38076967)
2. Brouns J, Van Wely M, Burger M, Van Wijngaarden W. Comparison of two dose regimens of misoprostol for second-trimester pregnancy termination. Contraception 2010;82:266-275.
3. Carbonell JL, Torres MA, Reyes R, Ortega L, Garćýa-Gallego F, Sánchez C. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial. Contraception 2008;77:50-55.
4. Chai J, Tang OS, Hong QQ, Chen QF, Cheng LN, Ng E, Ho PC. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion. Hum Reprod 2009;24:320-324.
5. Department of Health. Available at: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsStatistics/DH-099285 (6 January 2011, date last assessed) 2010.
6. Dickinson J, Brownell P, Mcginnis K, Nathan E. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: worth the effort. Aust N Z J Obstet Gynaecol 2010;50:60-64.
7. FINLEX. FINLEXw-Ajantasainen lainsäädäntö: 24.3. 1970/239. Available at: http://www.finlex.fi/fi/laki/ajantasa/1970/19700239. (6 January 2011, date last assessed) 2010.
8. Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters 2008;16:162-172.
9. Grimes D. The choice of second trimester abortion method: evolution, evidence and ethics. Reprod Health Matters 2008;16:183-188.
10. Guttmacher Institute. Facts on Induced Abortion Worldwide. Guttmacher Institute. Available at: http://www.guttmacher.org/pubs/fb-IAW.html (6 January 2011, date last accessed) 2010.
11. Hamoda H, Ashok PW, Flett GM, Templeton A. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation. Hum Reprod 2005;20:2348-2354. (Pubitemid 41418530)
12. Heikinheimo O, Suhonen S, Haukkamaa M. One-and 2-day mifepristone- misoprostol intervals are both effective in medical termination of second-trimester pregnancy. Reprod Biomed Online 2004;8:236-239. (Pubitemid 38213094)
13. Hou S, Zhang L, Chen Q, Fang A, Cheng L. One-and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16weeks of gestation. Int J Gynaecol Obstet 2010;111:126-130.
14. Lee VC, Ng EH, Ho PC. Issues in second trimester induced abortion (medical/surgical methods). Best Prac Res Clin Obstet Gynaecol 2010; 24:517-527.
15. Lohr PA, Hayes JL, Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database Syst Rev 2008:CD006714. DOI: 10.1002/14651858.CD006714.pub2. (Pubitemid 351807706)
16. Mentula MJ, Niinimäki M, Suhonen S, Hemminki E, Gissler M, Heikinheimo O. Young age and termination of pregnancy during the second trimester are risk factors for repeat second-trimester abortion. Am J Obstet Gynecol 2010;203:107.e1-7.
17. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857-872. (Pubitemid 28185165)
18. Ngai SW, Tang OS, Ho PC. Prostaglandins for induction of second-trimester termination and intrauterine death. Best Prac Res Clin Obstet Gynaecol 2003;17:765-775. (Pubitemid 37168293)
19. Nilas L, Glavind-Kristensen M, Vejborg T, Knudsen UB. One or two day mifepristone-misoprostol interval for second trimester abortion. Acta obstetricia et gynecologica Scandinavica 2007; 86:1117-1121. (Pubitemid 47345791)
20. R Development Core Team. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2010;1. http://www.r-project.org (June 2011, date last accessed).
21. Socialstyrelsen. Official statistics of Sweden 2010. http://www. socialstyrelsen.se/publikationer2011/2011-6-1 (June 2011, date last accessed).
22. Swahn ML, Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. BJOG 1988;95:126-134.
23. Tang OS, Chan CC, Kan AS, Ho PC. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation. Hum Reprod 2005;20:3062-3066. (Pubitemid 41662656)
24. THL. Induced abortions-reproduction-statistics by themes-stakes. Available at: http://www.stakes.fi/EN/tilastot/statisticsbytopic/reproduction/ abortions.htm. (6 January 2011, date last assessed) 2010.
25. Valvira. Valvira.fi2010. Available at: http://www.valvira.fi/en/(6 January 2011, date last accessed).